Literature DB >> 33501621

Moderating effect of sense of coherence on the relationship between symptom distress and health-related quality of life in patients receiving cancer chemotherapy.

Kaori Asaba1, Akiko Okawa2.   

Abstract

PURPOSE: This study is aimed at examining the buffering effect of sense of coherence (SOC) on symptom distress during cancer drug therapy, which thereby affects health-related quality of life (QoL), and obtaining suggestions for promoting supportive care.
METHODS: We investigated health-related QoL (SF-8), symptom distress (using the Symptom Distress Scale (SDS)), and SOC (the SOC 13-item Scale) in 66 patients receiving adjuvant chemotherapy for non-small cell lung cancer. We employed descriptive statistics to seek the correlation of each variable; then, a hierarchical multiple regression analysis was conducted with SF-8 score as the dependent variable.
RESULTS: Results showed that significant changes in bodily pain showed a buffering effect on the SDS and sense of comprehensibility (β = - 0.658, p < 0.01, β = - 0.319, p < 0.05), sense of manageability (β = - 0.658, p < 0.01, β = 0.398, p < 0.01), and meaningfulness (β = - 0.658, p < 0.01, β = - 0.257, p < 0.05). Significant changes in general health perception showed a buffering effect on the SDS and sense of manageability (β = - 0.406, p < 0.01, β = 0.329, p < 0.05). As a result of the simple inclination test, SOC proved to be effective under high levels of symptom distress; the buffering effect of sense of manageability was reversed regarding bodily pain; and when meaningfulness was lower, it had a positive effect on QoL.
CONCLUSION: This study revealed that SOC exerts a buffering effect in situations where symptoms are highly painful. It also revealed that the effect of SOC was reversed for bodily pain and that a high SOC had a negative effect on QoL.

Entities:  

Keywords:  Cancer chemotherapy; Cancer patient; Quality of life; Sense of coherence; Symptom distress

Mesh:

Year:  2021        PMID: 33501621     DOI: 10.1007/s00520-021-06003-4

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  15 in total

1.  Assessing and managing depression in the terminally ill patient. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians - American Society of Internal Medicine.

Authors:  S D Block
Journal:  Ann Intern Med       Date:  2000-02-01       Impact factor: 25.391

2.  A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.

Authors:  Harubumi Kato; Yukito Ichinose; Morio Ohta; Enjo Hata; Noriaki Tsubota; Hirohito Tada; Yoh Watanabe; Hiromi Wada; Masahiro Tsuboi; Nobuyuki Hamajima; Mitsuo Ohta
Journal:  N Engl J Med       Date:  2004-04-22       Impact factor: 91.245

3.  Development of a symptom distress scale.

Authors:  R McCorkle; K Young
Journal:  Cancer Nurs       Date:  1978-10       Impact factor: 2.592

Review 4.  Antonovsky's sense of coherence scale and its relation with quality of life: a systematic review.

Authors:  Monica Eriksson; Bengt Lindström
Journal:  J Epidemiol Community Health       Date:  2007-11       Impact factor: 3.710

Review 5.  Relations of meaning in life and sense of coherence to distress in cancer patients: a meta-analysis.

Authors:  Joseph G Winger; Rebecca N Adams; Catherine E Mosher
Journal:  Psychooncology       Date:  2015-03-18       Impact factor: 3.894

6.  Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan.

Authors:  Kazuo Tamura; Keisuke Aiba; Toshiaki Saeki; Yoichi Nakanishi; Toshiharu Kamura; Hideo Baba; Kazuhiro Yoshida; Nobuyuki Yamamoto; Yuko Kitagawa; Yoshihiko Maehara; Mototsugu Shimokawa; Koichi Hirata; Masaki Kitajima
Journal:  Int J Clin Oncol       Date:  2015-02-15       Impact factor: 3.402

7.  Early palliative care for patients with metastatic non-small-cell lung cancer.

Authors:  Jennifer S Temel; Joseph A Greer; Alona Muzikansky; Emily R Gallagher; Sonal Admane; Vicki A Jackson; Constance M Dahlin; Craig D Blinderman; Juliet Jacobsen; William F Pirl; J Andrew Billings; Thomas J Lynch
Journal:  N Engl J Med       Date:  2010-08-19       Impact factor: 91.245

8.  Efficacy of aprepitant in patients with advanced or recurrent lung cancer receiving moderately emetogenic chemotherapy.

Authors:  Junji Uchino; Ryosuke Hirano; Naoki Tashiro; Yuji Yoshida; Shinichiro Ushijima; Takemasa Matsumoto; Keiichi Ohta; Keita Nakatomi; Koichi Takayama; Masaki Fujita; Yoichi Nakanishi; Kentaro Watanabe
Journal:  Asian Pac J Cancer Prev       Date:  2012

9.  Patient and health care provider perceptions of cancer-related fatigue and pain.

Authors:  Loretta A Williams; Chet Bohac; Sharon Hunter; David Cella
Journal:  Support Care Cancer       Date:  2016-05-20       Impact factor: 3.603

10.  Development of health-related quality of life and symptoms of anxiety and depression among persons diagnosed with cancer during adolescence: a 10-year follow-up study.

Authors:  Malin Ander; Helena Grönqvist; Martin Cernvall; Gunn Engvall; Mariann Hedström; Gustaf Ljungman; Johan Lyhagen; Elisabet Mattsson; Louise von Essen
Journal:  Psychooncology       Date:  2015-09-10       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.